ADHD: Clinical Trials

2 trials for ADHD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow ADHD: new trials by email Literature Review of ADHD trials Research Report on ADHD

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
NRCT-101SR, NRCT-202XR - ADHD
Phase 2TerminatedNeurocentria, Inc.22025-02-252026-01-15
Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD
Cannabis oil - ADHD, Hyperactivity
Phase 2TerminatedBrlev Agricultural Crops Ltd82022-07-312023-04-25

Narrower conditions

Attention Deficit Disorder with Hyperactivity (2)  ·  Spasm (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (2)  ·  Mental Disorders (2)  ·  Neurodevelopmental Disorders (2)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

nabiximols (1)

Sponsors

Brlev Agricultural Crops Ltd (1)  ·  Neurocentria, Inc. (1)

Countries

Israel (1)  ·  United States (1)

Top investigators

Guy Bar-Klein, PhD (1)  ·  Mati Berkovitch (1)

Results publications

PMID 25733754, PMID 28576350